 |
 |
 |
|
Excellent Virological and Immunological Response to Dolutegravir despite Extensive RT, PR and INI Resistance
|
|
|
Reported by Jules Levin
International Workshop on Antiviral Drug Resistance
June 3-7 2014, Berlin, Germany
L.M. Hofstra, M. Nijhuis, T. Mudrikova, A. Fun, P.J. Schipper, M. Schneider, A.M.J. Wensing
Virology, Dept. of Medical Microbiology and Dept. of Infectious Diseases & Internal Medicine, University Medical Center Utrecht,The Netherlands





|
|
|
 |
 |
|
|